tiprankstipranks
Trending News
More News >
Exela Technologies Inc (XELA)
OTHER OTC:XELA

Exela Technologies (XELA) AI Stock Analysis

Compare
1,253 Followers

Top Page

XE

Exela Technologies

(OTC:XELA)

29Underperform
Exela Technologies faces substantial financial and operational challenges. While there is some revenue growth and operational improvements, the significant financial instability, declining margins, and NASDAQ delisting present considerable risks. The technical analysis and valuation metrics further reflect the company's precarious position, resulting in a low overall stock score.

Exela Technologies (XELA) vs. S&P 500 (SPY)

Exela Technologies Business Overview & Revenue Model

Company DescriptionExela Technologies (XELA) is a global business process automation (BPA) company operating primarily across the United States and Europe. It provides digital transformation solutions for a wide array of industries, including banking, healthcare, insurance, and legal. The company's core services include information management, workflow automation, and integrated communication services, which help organizations improve efficiency and reduce operational costs.
How the Company Makes MoneyExela Technologies generates revenue through a combination of software-as-a-service (SaaS) offerings, business process outsourcing (BPO), and transaction-based services. Its key revenue streams include subscription fees for its software platforms, fees for managed services, and charges for transaction processing and document management services. Exela often forms strategic partnerships with large enterprises to provide customized automation solutions, contributing significantly to its earnings. These partnerships allow for long-term contracts that ensure a steady flow of income. Additionally, the company benefits from cross-selling opportunities across its product portfolio, leveraging its extensive client base to promote complementary services.

Exela Technologies Financial Statement Overview

Summary
Exela Technologies exhibits severe financial challenges, with declining revenues, high leverage, and negative equity. The company struggles with profitability and operational efficiency. Although there are minor improvements in cash flow, the overall financial health remains precarious.
Income Statement
25
Negative
Exela Technologies shows a severe decline in revenue over recent years, with a negative revenue growth rate from the previous annual period to the TTM. Gross profit margin and net profit margin are significantly low, reflecting operational inefficiencies and persistent net losses. Despite some improvement in EBITDA, the company remains unprofitable, with negative EBIT and net income margins.
Balance Sheet
15
Very Negative
The balance sheet reveals a highly leveraged position with a negative equity, indicating financial instability and potential insolvency risks. The debt-to-equity ratio is not calculable due to negative equity, but the significant liabilities overshadow the assets. Return on equity is negative, further highlighting the company's financial struggles.
Cash Flow
30
Negative
The cash flow statement indicates a modest improvement in operating cash flow in the TTM, but free cash flow remains low. There is a slight positive free cash flow growth rate compared to the previous year, yet the overall cash flow health remains weak due to consistent negative net income impacting the operating cash flow to net income ratio.
Breakdown
TTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
1.04B1.06B1.08B1.17B1.29B1.56B
Gross Profit
198.57M230.70M199.68M277.51M269.02M337.60M
EBIT
-14.41M8.05M-70.81M21.39M18.52M12.94M
EBITDA
47.96M84.63M-174.68M114.46M102.89M-237.12M
Net Income Common Stockholders
-104.98M-125.16M-415.58M-142.39M-178.53M-509.12M
Balance SheetCash, Cash Equivalents and Short-Term Investments
25.61M25.28M15.07M20.77M68.22M6.20M
Total Assets
1.64B636.34M721.91M1.04B1.16B1.26B
Total Debt
1.38B1.11B1.15B1.32B1.64B1.57B
Net Debt
1.35B1.09B1.14B1.30B1.57B1.56B
Total Liabilities
1.82B1.50B1.53B1.70B2.08B2.00B
Stockholders Equity
-181.01M-855.50M-807.59M-666.77M-926.53M-743.04M
Cash FlowFree Cash Flow
10.89M-8.34M-109.13M-128.06M-45.27M-84.39M
Operating Cash Flow
20.56M3.56M-87.16M-111.53M-29.78M-63.85M
Investing Cash Flow
-9.11M17.92M-21.77M-9.26M21.44M-25.18M
Financing Cash Flow
-11.52M624.00K106.64M98.65M63.36M59.14M

Exela Technologies Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.48
Price Trends
50DMA
0.52
Negative
100DMA
0.78
Negative
200DMA
1.44
Negative
Market Momentum
MACD
-0.03
Negative
RSI
45.29
Neutral
STOCH
13.87
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XELA, the sentiment is Negative. The current price of 0.48 is above the 20-day moving average (MA) of 0.48, below the 50-day MA of 0.52, and below the 200-day MA of 1.44, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 45.29 is Neutral, neither overbought nor oversold. The STOCH value of 13.87 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for XELA.

Exela Technologies Risk Analysis

Exela Technologies disclosed 42 risk factors in its most recent earnings report. Exela Technologies reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Exela Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
GG
80
Outperform
$8.45B16.9022.15%1.30%6.46%-16.94%
DODOX
73
Outperform
$9.57B19.6614.13%2.30%-1.55%-7.26%
57
Neutral
$20.24B9.51-13.28%2.72%5.43%-24.54%
FIFIS
51
Neutral
$38.35B51.064.65%2.04%-17.38%
DXDXC
47
Neutral
$2.82B267.98-2.46%-5.65%78.20%
42
Neutral
$365.74M0.9948.63%-9.83%
29
Underperform
$11.38M11.21%-2.68%94.28%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
XELA
Exela Technologies
0.48
-1.88
-79.66%
DOX
Amdocs
82.21
-1.55
-1.85%
FIS
Fidelity National Info
69.51
-0.11
-0.16%
G
Genpact
46.71
15.97
51.95%
CNDT
Conduent
2.13
-1.07
-33.44%
DXC
DXC Technology
14.25
-6.05
-29.80%

Exela Technologies Earnings Call Summary

Earnings Call Date: Apr 2, 2025 | % Change Since: 4.35% | Next Earnings Date: May 8, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mix of positive revenue growth and operational efficiencies with significant challenges in margin decline, net loss, and NASDAQ delisting. While there are promising growth opportunities and improvements, the financial struggles and delisting weigh heavily.
Highlights
Revenue Growth
Third quarter revenues were $269.2 million, up 6.3% year-over-year. Information and Transaction Processing Solutions increased by 11.5% year-over-year.
Sequential Improvements
Sequentially, Q3 was up 22.4% in ITPS, primarily driven by a large project from an existing customer. Adjusted EBITDA improved by 6.7% sequentially.
Operational Efficiency
SG&A was down about 1% year-over-year and 16% sequentially due to reductions in legal and professional fees and employee-related costs. The company is shifting from CapEx to OpEx by moving data center infrastructure to the cloud.
New Business Achievements
The company renewed over $113 million of TCV in the quarter, won approximately $40 million of new ACV, and added 81 new logos.
Improved Cash Flow
Cash flow from operations improved with $5 million of positive cash flow in Q3.
Lowlights
Gross Margin Decline
Q3 gross margins were 20.2%, down 330 basis points sequentially and 140 basis points year-over-year due to higher postage costs.
Segment Performance Decline
Healthcare Solutions and Legal and Loss Prevention Services declined by 5.3% and 2.4% year-over-year, respectively. LLPS was down 28.8% sequentially due to project fluctuations.
Net Loss
The company reported a net loss of $24.9 million, although it was an improvement of $2 million sequentially.
NASDAQ Delisting
Exela was delisted from NASDAQ due to failure to meet the Exchange's $35 million market cap minimum requirement for 30 consecutive business days.
Company Guidance
During the Exela Third Quarter 2024 Earnings Call, interim CFO Matt Brown provided detailed financial guidance, highlighting a 6.3% year-over-year increase in revenues, reaching $269.2 million. Information and Transaction Processing Solutions (ITPS) grew by 11.5% year-over-year and 22.4% sequentially, driven by a large project from an existing customer, while Healthcare Solutions and Legal and Loss Prevention Services (LLPS) saw declines of 5.3% and 2.4% year-over-year, respectively. Gross margins dropped by 330 basis points sequentially and 140 basis points year-over-year, primarily due to increased postage costs. Exela achieved a net loss of $24.9 million, a $2 million improvement sequentially, with adjusted EBITDA at $14.6 million and a 6.7% sequential improvement. The company renewed over $113 million in Total Contract Value (TCV) and added approximately $40 million in Annual Contract Value (ACV) with 81 new logos. Despite being delisted from NASDAQ, Exela remains focused on growing revenue, improving gross margins, and enhancing profitability and liquidity.
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.